Back
Faro Technologies 10K Form
Sell
47
FARO
Faro Technologies
Last Price:
$29.46
Seasonality Move:
-2.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | FARO/Faro Technologies Quarterly |
2023-11-01 | 10Q | FARO/Faro Technologies Quarterly |
2023-08-02 | 10Q | FARO/Faro Technologies Quarterly |
2023-05-08 | 10Q | FARO/Faro Technologies Quarterly |
2022-11-02 | 10Q | FARO/Faro Technologies Quarterly |
2022-08-03 | 10Q | FARO/Faro Technologies Quarterly |
Receive FARO News And Ratings
See the #1 stock for the next 7 days that we like better than FARO
FARO Financial Statistics
Sales & Book Value
Annual Sales: | $342.4M |
---|---|
Cash Flow: | $12.5M |
Price / Cash Flow: | 32.32 |
Annual Sales: | $13.17 |
Price / Book: | 2.24 |
Profitability
EPS (TTM): | -0.48000 |
---|---|
Net Income (TTM): | $-9.1M |
Gross Margin: | $187.2M |
Return on Equity: | -3.51% |
Return on Assets: | -1.85% |
Faro Technologies Earnings Forecast
Key Faro Technologies Financial Ratios
-
The Gross Profit Margin over the past 29 years for FARO is 54.65%.
-
The Selling, General & Administrative Expenses for FARO have been equal to 41.06% of Gross Profit Margin.
-
The Research & Development expenses have been 11.70% of Revenue.
-
The Net Earning history of FARO is -2.65% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 13 years.
Faro Technologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Electronic Equipment, Instruments & Components |
Sector: | Information Technology |
Current Symbol: | FARO |
CUSIP: | 311642 |
Website: | faro.com |
Debt
Debt-to-Equity Ratio: | 0.28 |
---|---|
Current Ratio: | 2.2 |
Quick Ratio: | 1.75 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 20.95 |
FARO Technical Analysis vs Fundamental Analysis
Sell
47
Faro Technologies (FARO)
is a Sell
Is Faro Technologies a Buy or a Sell?
-
Faro Technologies stock is rated a SellThe current Faro Technologies [FARO] share price is $29.43. The Score for FARO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.